Additional effects of paclitaxel include the triggering of macrophages for TNFα and IL-1 production[57] and its antiangiogenic activity by downregulating VEGF and Ang-1 expression in tumor cells and by increasing the secretion of TSP-1 in the tumor microenvironment[58]. This evidence concerns the gene VEGFA and neoplasm.